Search by Drug Name or NDC

NDC 00009-5190-01 Detrol LA 2 mg/1 Details

Detrol LA 2 mg/1

Detrol LA is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pharmacia and Upjohn Company LLC. The primary component is TOLTERODINE TARTRATE.

MedlinePlus Drug Summary

Tolterodine is used treat overactive bladder (a condition in which the bladder muscles contract uncontrollably and cause frequent urination, urgent need to urinate, and inability to control urination). Tolterodine is in a class of medications called antimuscarinics. It works by relaxing the bladder muscles preventing bladder contraction.

Related Packages: 00009-5190-01
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tolterodine

Product Information

NDC	00009-5190
Product ID	0009-5190_59d526b1-16f4-41b8-84da-5843d66551d6
Associated GPIs	54100060207020
GCN Sequence Number	047328
GCN Sequence Number Description	tolterodine tartrate CAP ER 24H 2 MG ORAL
HIC3	R1A
HIC3 Description	URINARY TRACT ANTISPASMODIC/ANTIINCONTINENCE AGENT
GCN	12264
HICL Sequence Number	018047
HICL Sequence Number Description	TOLTERODINE TARTRATE
Brand/Generic	Brand
Proprietary Name	Detrol LA
Proprietary Name Suffix	n/a
Non-Proprietary Name	tolterodine tartrate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	2
Active Ingredient Units	mg/1
Substance Name	TOLTERODINE TARTRATE
Labeler Name	Pharmacia and Upjohn Company LLC
Pharmaceutical Class	Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA021228
Listing Certified Through	n/a

Package

NDC 00009-5190-01 (00009519001)

Pricing Information	N/A
NDC Package Code	0009-5190-01
Billing NDC	00009519001
Package	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0009-5190-01)
Marketing Start Date	2000-02-22
NDC Exclude Flag	N